Delivery Order SPE2DP20D0002-SPE2DP25F4436

This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The contract has a ceiling value of $165,156.93 and a period of performance through March 25, 2025. Teva is a major pharmaceutical supplier to federal agencies, providing critical medical products including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs to various government healthcare programs. This award is part of Teva's ongoing support for military immunization programs, as the company has consistently received federal contract awards, predominantly from DLA, for the delivery of Adenovirus Type 4 vaccine. The contract does not have a set-aside designation, and Teva competes as a large business. In addition to this delivery order, Teva holds two significant Indefinite Delivery Contracts (IDCs) with federal agencies for the supply of glatiramer acetate injections and Levalbuterol HCL solution, further demonstrating the company's critical role in maintaining pharmaceutical supplies for federal healthcare programs.